NL6714191A - - Google Patents

Info

Publication number
NL6714191A
NL6714191A NL6714191A NL6714191A NL6714191A NL 6714191 A NL6714191 A NL 6714191A NL 6714191 A NL6714191 A NL 6714191A NL 6714191 A NL6714191 A NL 6714191A NL 6714191 A NL6714191 A NL 6714191A
Authority
NL
Netherlands
Application number
NL6714191A
Other versions
NL151693B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6714191A publication Critical patent/NL6714191A/xx
Publication of NL151693B publication Critical patent/NL151693B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/48Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation involving decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL676714191A 1966-10-19 1967-10-19 Werkwijze voor het bereiden van een geneesmiddel met een bronchospasmolytische werking dat een derivaat van 2-amino-1-(3,5-dihydroxyfenyl)ethanol bevat en het onder toepassing van deze werkwijze verkregen gevormde geneesmiddel met een bronchospasmolytische werking en werkwijze voor het bereiden van een geneeskrachtig 2-amino-1-(3,5-dihydroxyfenyl)ethanolderivaat, dat als actief bestanddeel in zo'n geneesmiddel wordt toegepast. NL151693B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE14182/66A SE335359B (en:Method) 1966-10-19 1966-10-19

Publications (2)

Publication Number Publication Date
NL6714191A true NL6714191A (en:Method) 1968-04-22
NL151693B NL151693B (nl) 1976-12-15

Family

ID=20298669

Family Applications (2)

Application Number Title Priority Date Filing Date
NL676714191A NL151693B (nl) 1966-10-19 1967-10-19 Werkwijze voor het bereiden van een geneesmiddel met een bronchospasmolytische werking dat een derivaat van 2-amino-1-(3,5-dihydroxyfenyl)ethanol bevat en het onder toepassing van deze werkwijze verkregen gevormde geneesmiddel met een bronchospasmolytische werking en werkwijze voor het bereiden van een geneeskrachtig 2-amino-1-(3,5-dihydroxyfenyl)ethanolderivaat, dat als actief bestanddeel in zo'n geneesmiddel wordt toegepast.
NL7513854A NL7513854A (nl) 1966-10-19 1975-11-27 Werkwijze voor het bereiden van een geneesmiddel met bronchospasmolytische werking dat een of een aantal derivaten van 2-amino-1-(3,5-dihydroxyfenyl)- -ethanol bevat en de onder toepassing van deze werkwij- ze verkregen gevormde geneesmiddelen met bronchospasmo- lytyische werking en werkwijze voor het bereiden van ge-neeskrachtige 2-amino-1-(3,5-dihydroxyfenyl)-ethanol- derivaten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7513854A NL7513854A (nl) 1966-10-19 1975-11-27 Werkwijze voor het bereiden van een geneesmiddel met bronchospasmolytische werking dat een of een aantal derivaten van 2-amino-1-(3,5-dihydroxyfenyl)- -ethanol bevat en de onder toepassing van deze werkwij- ze verkregen gevormde geneesmiddelen met bronchospasmo- lytyische werking en werkwijze voor het bereiden van ge-neeskrachtige 2-amino-1-(3,5-dihydroxyfenyl)-ethanol- derivaten.

Country Status (13)

Country Link
AT (4) AT288356B (en:Method)
BE (1) BE704932A (en:Method)
CH (1) CH510625A (en:Method)
DE (2) DE1643296C3 (en:Method)
DK (2) DK128491B (en:Method)
ES (5) ES346131A1 (en:Method)
FI (1) FI50786C (en:Method)
FR (1) FR8011M (en:Method)
GB (1) GB1199630A (en:Method)
IT (1) IT8048168A0 (en:Method)
NL (2) NL151693B (en:Method)
NO (1) NO120686B (en:Method)
SE (1) SE335359B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138581A (en) 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
DE3163114D1 (en) * 1980-07-09 1984-05-17 Draco Ab Therapeutically active derivatives of phenylethanol amines
US4853381A (en) * 1984-04-17 1989-08-01 Glaxo Group Limited Ethanolamine compounds
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
EP0213108A3 (de) * 1985-06-26 1987-07-15 Kurt Dr. Burghart Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
WO2013081565A1 (en) 2011-11-21 2013-06-06 Mahmut Bilgic Pharmaceutical compositions comprising roflumilast and terbutaline
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
WO2018182546A1 (en) 2017-03-27 2018-10-04 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
CN110057932B (zh) * 2019-04-22 2022-03-15 上海旭东海普药业有限公司 高效液相色谱分析硫酸特布他林有关物质的方法
CN111440078A (zh) * 2020-04-26 2020-07-24 梯尔希(南京)药物研发有限公司 特布他林衍生物的制备方法
CN113264839B (zh) * 2021-04-27 2022-08-30 苏州弘森药业股份有限公司 一种使用手性辅基制备左旋特布他林的方法
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (zh) 2023-01-20 2025-09-02 阿托基公司 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138581A (en) 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols

Also Published As

Publication number Publication date
CH510625A (de) 1971-07-31
DE1793759C3 (de) 1979-01-11
ES361433A1 (es) 1970-11-01
DE1793759A1 (de) 1973-08-16
DE1643296B2 (de) 1973-10-25
ES361429A1 (es) 1970-11-01
NO120686B (en:Method) 1970-11-23
FI50786B (en:Method) 1976-03-31
BE704932A (en:Method) 1968-02-15
DE1793759B2 (de) 1978-05-11
AT288356B (de) 1971-03-10
DK468876A (da) 1976-10-18
DE1643296A1 (de) 1971-09-30
AT286964B (de) 1971-01-11
NL151693B (nl) 1976-12-15
AT287678B (de) 1971-02-10
FI50786C (fi) 1976-07-12
IT8048168A0 (it) 1980-03-14
AT287679B (de) 1971-02-10
SE335359B (en:Method) 1971-05-24
FR8011M (en:Method) 1970-07-27
ES361432A1 (es) 1970-11-01
ES361431A1 (es) 1970-11-01
ES346131A1 (es) 1969-05-16
DK128491B (da) 1974-05-13
NL7513854A (nl) 1976-03-31
DE1643296C3 (de) 1974-06-12
GB1199630A (en) 1970-07-22

Similar Documents

Publication Publication Date Title
AU5917865A (en:Method)
AU424443B2 (en:Method)
AU1534566A (en:Method)
AU414526B2 (en:Method)
AU415165B1 (en:Method)
AU421822B2 (en:Method)
AU417216B2 (en:Method)
AU433222B2 (en:Method)
AU6703465A (en:Method)
AU612166A (en:Method)
AU5895065A (en:Method)
AU218666A (en:Method)
AU1144366A (en:Method)
AU6852465A (en:Method)
BE624223A (en:Method)
AU433620A (en:Method)
AU414093B2 (en:Method)
AU411645B2 (en:Method)
AU407778B2 (en:Method)
AU2390066A (en:Method)
BE666282A (en:Method)
BE654686A (en:Method)
AU855865A (en:Method)
AU92366A (en:Method)
BE662818A (en:Method)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: DRACO

V4 Discontinued because of reaching the maximum lifetime of a patent